AI Engines For more Details: Perplexity Kagi Labs You
| Rank | Probiotic | Impact |
|---|---|---|
| species | Akkermansia muciniphila | Increases |
| species | Bacteroides acidifaciens | Increases |
| species | Bacteroides finegoldii | Increases |
| species | Bacteroides gallinarum | Increases |
| species | Bacteroides intestinalis | Increases |
| species | Bacteroides propionicifaciens | Increases |
| species | Bacteroides uniformis | Increases |
| species | Bacteroides xylanisolvens | Increases |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Abdominal Aortic Aneurysm | 0.2 | -0.2 | |
| Acne | 0.5 | 0.9 | -0.8 |
| ADHD | 0.4 | -0.4 | |
| Allergic Rhinitis (Hay Fever) | 0.3 | 0.6 | -1 |
| Allergies | 1.8 | 0.8 | 1.25 |
| Allergy to milk products | 0.6 | 1.2 | -1 |
| Alopecia (Hair Loss) | 0.5 | 0.1 | 4 |
| Alzheimer's disease | 2.9 | 2.1 | 0.38 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.6 | 1.7 | -1.83 |
| Ankylosing spondylitis | 0.6 | 1.7 | -1.83 |
| Anorexia Nervosa | 0.8 | 0.8 | |
| Antiphospholipid syndrome (APS) | 0.8 | 0.2 | 3 |
| Asthma | 1.5 | 1.1 | 0.36 |
| Atherosclerosis | 2.2 | 0.8 | 1.75 |
| Atrial fibrillation | 1.1 | 0.8 | 0.38 |
| Autism | 1.7 | 2 | -0.18 |
| Autoimmune Disease | 0.5 | 0.5 | |
| Barrett esophagus cancer | 0.5 | 0.5 | |
| benign prostatic hyperplasia | 0.6 | 0.6 | |
| Bipolar Disorder | 0.3 | 0.6 | -1 |
| Brain Trauma | 0.6 | 0.6 | |
| Cancer (General) | 0.1 | 0.1 | |
| Carcinoma | 0.6 | 0.6 | 0 |
| Celiac Disease | 1.9 | 1.1 | 0.73 |
| Cerebral Palsy | 0.6 | 0.9 | -0.5 |
| Chronic Fatigue Syndrome | 0.6 | 1.3 | -1.17 |
| Chronic Kidney Disease | 0.3 | 0.7 | -1.33 |
| Chronic Lyme | 0.6 | 0.6 | |
| Chronic Urticaria (Hives) | 0.8 | 0.8 | |
| Coagulation / Micro clot triggering bacteria | 0.5 | 0.5 | |
| Cognitive Function | 0.6 | 1.2 | -1 |
| Colorectal Cancer | 2.7 | 2 | 0.35 |
| Constipation | 0.3 | 0.9 | -2 |
| Coronary artery disease | 1.3 | 1.3 | |
| COVID-19 | 3.5 | 3.3 | 0.06 |
| Crohn's Disease | 2 | 1.8 | 0.11 |
| Cushing's Syndrome (hypercortisolism) | 0.6 | 0.6 | |
| cystic fibrosis | 0.6 | 0.6 | |
| deep vein thrombosis | 1.1 | 0.5 | 1.2 |
| Denture Wearers Oral Shifts | 0.2 | 0.2 | |
| Depression | 1.9 | 3 | -0.58 |
| Eczema | 0.2 | 0.3 | -0.5 |
| Endometriosis | 0.6 | -0.6 | |
| Eosinophilic Esophagitis | 0.5 | 0.5 | |
| Epilepsy | 1.5 | 1.1 | 0.36 |
| erectile dysfunction | 0.6 | 0.6 | 0 |
| Fibromyalgia | 1.4 | 1.4 | |
| Functional constipation / chronic idiopathic constipation | 1.4 | 1.3 | 0.08 |
| gallstone disease (gsd) | 0.8 | 0.2 | 3 |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.6 | 0.7 | 1.29 |
| Generalized anxiety disorder | 1.1 | 0.9 | 0.22 |
| Gout | 0.8 | 1.9 | -1.37 |
| Graves' disease | 1.4 | 0.6 | 1.33 |
| Gulf War Syndrome | 1.2 | 0.3 | 3 |
| Halitosis | 1 | 0.6 | 0.67 |
| Hashimoto's thyroiditis | 1.4 | 1.1 | 0.27 |
| Heart Failure | 1.3 | 0.6 | 1.17 |
| Hidradenitis Suppurativa | 0.6 | -0.6 | |
| hypercholesterolemia (High Cholesterol) | 0.6 | 0.6 | |
| hyperglycemia | 2 | 2 | |
| Hyperlipidemia (High Blood Fats) | 0.8 | 0.3 | 1.67 |
| hypertension (High Blood Pressure | 1.5 | 2 | -0.33 |
| Hypothyroidism | 0.5 | 0.9 | -0.8 |
| Hypoxia | 1.7 | -1.7 | |
| IgA nephropathy (IgAN) | 1.9 | 0.6 | 2.17 |
| Inflammatory Bowel Disease | 2.2 | 1.5 | 0.47 |
| Insomnia | 1.9 | 0.6 | 2.17 |
| Intelligence | 0.8 | -0.8 | |
| Intracranial aneurysms | 0.6 | -0.6 | |
| Irritable Bowel Syndrome | 2.5 | 2.2 | 0.14 |
| ischemic stroke | 1.6 | 1.2 | 0.33 |
| Liver Cirrhosis | 1.5 | 1.1 | 0.36 |
| Long COVID | 1.3 | 1.4 | -0.08 |
| Lung Cancer | 0.6 | 0.1 | 5 |
| Mast Cell Issues / mastitis | 0.5 | 0.5 | |
| ME/CFS with IBS | 0.6 | 0.6 | |
| ME/CFS without IBS | 0.6 | 0.6 | |
| membranous nephropathy | 0.3 | 0.3 | |
| Menopause | 0.3 | 0.5 | -0.67 |
| Metabolic Syndrome | 2.4 | 1.7 | 0.41 |
| Mood Disorders | 1.9 | 3.6 | -0.89 |
| multiple chemical sensitivity [MCS] | 0.3 | -0.3 | |
| Multiple Sclerosis | 0.8 | 0.9 | -0.13 |
| Multiple system atrophy (MSA) | 0.9 | -0.9 | |
| myasthenia gravis | 0.5 | -0.5 | |
| neuropathic pain | 0.9 | 0.9 | |
| Neuropathy (all types) | 1.1 | 0.3 | 2.67 |
| neuropsychiatric disorders (PANDAS, PANS) | 0.3 | -0.3 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2.5 | 0.8 | 2.13 |
| NonCeliac Gluten Sensitivity | 0.6 | 1.2 | -1 |
| Obesity | 3 | 1.5 | 1 |
| obsessive-compulsive disorder | 1.2 | 1.2 | 0 |
| Osteoarthritis | 0.9 | 0.8 | 0.13 |
| Osteoporosis | 1.7 | 0.6 | 1.83 |
| pancreatic cancer | 0.6 | 0.6 | |
| Parkinson's Disease | 1.6 | 2 | -0.25 |
| Polycystic ovary syndrome | 1.2 | 1.1 | 0.09 |
| primary biliary cholangitis | 0.2 | 0.2 | |
| Primary sclerosing cholangitis | 0.6 | -0.6 | |
| Psoriasis | 1.7 | 0.5 | 2.4 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 1.9 | 1.2 | 0.58 |
| Rosacea | 0.5 | 0.5 | |
| Schizophrenia | 1.2 | 1.4 | -0.17 |
| Sjögren syndrome | 0.8 | 0.5 | 0.6 |
| Sleep Apnea | 0.6 | 0.6 | |
| Slow gastric motility / Gastroparesis | 0.6 | -0.6 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.6 | -0.6 | |
| Stress / posttraumatic stress disorder | 1.3 | 0.9 | 0.44 |
| Systemic Lupus Erythematosus | 1.1 | -1.1 | |
| Tourette syndrome | 0.6 | 0.3 | 1 |
| Type 1 Diabetes | 1.4 | 1.6 | -0.14 |
| Type 2 Diabetes | 2.1 | 1.5 | 0.4 |
| Ulcerative colitis | 3.6 | 1.1 | 2.27 |
| Unhealthy Ageing | 0.3 | 0.8 | -1.67 |
| Vitiligo | 0.3 | 0.8 | -1.67 |
